Chris Witowski, PhD

Founder @psilera 🧠 Scientist 👨‍🔬 Fan @arsenal ⚽️ All opinions are my own

[Chris Witowski, PhD @ChemWit]

Yes to all of this. Sentiment far outweighs reality in terms of valuation and near-term approvals (most analysts will say the same) with massive TAM.

The only company I invest in is my own @psilera, a neuroplastogen biotech. 💊 This is not financial advice.

[BowTiedBiotech 🧪🔬🧬 @BowTiedBiotech]

📉 🍄BUY Low, Sell High Psychedelics?

The entire psychedelics sector remains deeply underwater from its pandemic-era highs, down >80% across $ATAI, $CMPS, and the $PSIL ETF.

🗣️But that might be exactly why it deserves another look.

🧠 New data from $ATAI / Beckley show that fast-acting intranasal 5-MeO-DMT (BPL-003) can deliver durable depression relief in just a 2-hour clinic session. That changes the economics: short sessions mean scalable models, like $JNJ’s Spravato blockbuster.

🇺🇸 Political momentum is real: MAHA advocates are vocal, FDA leadership is signaling support, and a path to P3 is now in motion.

🎯 Compass $CMPS is still weighed down by long psilocybin sessions and meh Ph3. But $ATAI is emerging with a cleaner story, tighter trial design, and asymmetric upside.

🔬 Gilgamesh is another sleeper to watch, with novel neuroplasticity assets designed to avoid the hallucination entirely, offering a pharma-friendly path if data hold up.

This is what early-stage contrarian biotech looks like:
📉 Sentiment wrecked
🧪 Data improving
⏱️ Timelines compressing
💰 TAM enormous

Buy when you can’t pitch it at dinner.

https://t.co/enBA3BRLdh

[Chris Witowski, PhD @ChemWit]

@AnthonyClose @BravesGators Having local government run a power company seems like a bad idea. But to use this as leverage against Duke I support (better rates, bury/insulate sensitive lines, etc).

[Chris Witowski, PhD @ChemWit]

I’d like to thank the entire Psilera team for their vision and dedication. Lastly, a big thank you to our investors for their support. We’re just getting started!

[Chris Witowski, PhD @ChemWit]

Proud to announce the formal close of Psilera’s seed round bringing our total funds raised to $9M. Couple this with our revenue generating deal (with additional upside) and #NIH funding it has been quite a year and change for us!

[Psilera @psilera]

Psilera has closed an oversubscribed $8.8M raised #SeriesSeed funding round!

#FirstInClass and #FirstInHuman data expected in 2027.

Read the full details in the press release below: https://t.co/xtQNi7yu7n

#MindfulMedicine #Psychedelics #Neuroplastogens

[Chris Witowski, PhD @ChemWit]

Even more important is this financing readies us for clinical trials with PSIL-006 next year. We are well-positioned with an industry-leading patent portfolio and a differentiated #neuroplastogen pipeline. Stay tuned for some big milestones over the next 12 months!

[Chris Witowski, PhD @ChemWit]

Anyone in SD for Bio next month?

[Psilera @psilera]

One month until #BIOConvention: where #biotech & #biopharma meet for #partnering and #innovation.

The team will be in #SanDiego sharing the latest #data from Psilera's #nextgeneration #psychedelic and #neuroplastogen pipeline.

Email [email protected] to schedule a meeting.

[Chris Witowski, PhD @ChemWit]

Wow

[HandofArsenal @HandofArsenal]

Guard of Honour then Budapest ❤️🙏🏽

[Chris Witowski, PhD @ChemWit]

This is my club. North London Forever, just getting started!!! #afc

[Arsenal @Arsenal]

The Arsenal. Your Premier League champions.

[Chris Witowski, PhD @ChemWit]

@zach_haigney Where do I sign up? This movie will be a banger.

[Chris Witowski, PhD @ChemWit]

Will be a great time in Miami with @Oppenheimer and other CNS leaders. We’re reaching a pivotal inflection in the #psychedelics and related #neuroplastogens.

Look forward to discussing these developments and the latest progress at @psilera.

[Psilera @psilera]

Co-Founder and CEO Chris Witowski, PhD, is a featured panelist at #Oppenheimer's #CNS Focus Event in #Miami 6/10/26

To meet with him and learn the latest about our #neuroplastogen pipeline, email us at [email protected]

#Innovation #Psychedelics #DrugDiscovery #MindfulMedicine

[Chris Witowski, PhD @ChemWit]

@zach_haigney @Arsenal Going the 3rd kit Eze #10 today but my alternate blue jersey from last year is real funky (the lucky one will be worn for the title decider).

[Chris Witowski, PhD @ChemWit]

@bankertobuilder I’ll take the one with the pool

[Chris Witowski, PhD @ChemWit]

@Josh__Hardman Welcome mate

[Chris Witowski, PhD @ChemWit]

Get ready, multiple #psychedelic drug approvals are coming. New options for patients, who often don’t respond to current treatments, is a great thing for depression and PTSD (~35 million in the US alone).

[U.S. FDA @US_FDA]

Following President Trump’s directive to accelerate medical treatments for serious mental illnesses, FDA announced major steps to support the development of serotonin-2A agonists & related products—a class of medications historically referred to as "psychedelic" drugs.

✅ National priority vouchers for psilocybin (for treatment-resistant depression and major depressive disorder)
✅ National priority voucher for methylone (for post-traumatic stress disorder)
✅ First-ever noribogaine study authorized for alcohol use disorder
✅ Advancing guidance for sponsors developing these products

Learn more: https://t.co/GZobFZ67Gh

[Chris Witowski, PhD @ChemWit]

A big headline this weekend with the signing of the Executive Order on #psychedelics.

[Psilera @psilera]

@Psilera is bolstered by the #ExecutiveOrder signed in support of advancing #psychedelictherapies to help patients in need!

https://t.co/pDc4YkVn4I

#Psychedelics #Psilocybin #Neuroplastogens #DrugInnovation #DrugDevelopment #MindfulMedicine

[Chris Witowski, PhD @ChemWit]

@AnthonyClose We need higher paying jobs. Florida should be trying everything to relocate businesses/Fortune 500s. Unfortunately our hospitality sectors (a large portion of our economy) don’t make enough to support a living. Schools/education are a problem too.

[Chris Witowski, PhD @ChemWit]

@ArsenalBuzzCom Gabi Jesus on the right as a 2nd striker

[Chris Witowski, PhD @ChemWit]

@NoLimitGains Wtf

[Chris Witowski, PhD @ChemWit]

@QuintinPope5 AI and infra going off the scale soon, esp with these circular deals. Same concentration in game-changing tech.